Metfozid Tablet

About Metfozid 2.5 mg + 250 mg Tablet

Metfozid 2.5 mg + 250 mg tablet is a medicine made by Orion Pharma Ltd. It helps lower both fasting and post-meal blood sugar levels.

There are 6 brands of Glipizide + Metformin Hydrochloride listed in Bangladesh. The lowest listed price is Mefoglip 2.5 mg + 250 mg Tablet at ৳ 1.9 per unit.

What is Metfozid 2.5 mg + 250 mg Tablet?

The tablet Metfozid contains Glipizide + Metformin Hydrochloride and is made by Orion Pharma Ltd. It is used under a doctor's supervision, and the dose is set by the doctor. That combines two oral diabetes medicines, Glipizide and Metformin Hydrochloride, in a strength of 2.5 mg + 250 mg. Use it only as your doctor directs.

Uses of Metfozid

It helps lower both fasting and post-meal blood sugar levels. It is prescribed when diet and exercise alone are not enough, or as a second-line treatment when other initial therapy has not worked. It can be started as initial therapy or used as second-line therapy when other treatments have not achieved satisfactory control. Your doctor will decide if it is suitable for you.

How to use Metfozid

The tablet is usually taken with meals, but the doctor will decide the dose and how often you take it. Swallow the tablet with water. Metfozid is taken by mouth. Do not change the dose or stop early without asking your doctor. If you miss a dose, ask your doctor or pharmacist what to do.

Side effects of Metfozid

If you experience severe or persistent side effects, contact your doctor. Do not ignore symptoms that worry you. Common side effects include low blood sugar (hypoglycemia), diarrhea, nausea, vomiting, abdominal pain, headache, and muscle or joint pain. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.

Safety and precautions

It should not be used if you have kidney problems, diabetic coma or ketoacidosis, chronic kidney disease, heart failure, trauma, dehydration, alcohol dependence, or if you are pregnant or breastfeeding. It is not recommended during pregnancy or breastfeeding. Older adults and those with reduced kidney function need careful dose adjustment. Tell your doctor about all your medical conditions and medicines before starting this tablet.

Frequently asked questions

What does Metfozid treat?

It helps lower both fasting and post-meal blood sugar levels. It is prescribed when diet and exercise alone are not enough, or as a second-line treatment when other initial therapy has not worked.

How is Metfozid used?

The tablet is usually taken with meals, but the doctor will decide the dose and how often you take it. Swallow the tablet with water.

What should I watch for while using Metfozid?

If you experience severe or persistent side effects, contact your doctor. Do not ignore symptoms that worry you.

Can I use Metfozid in pregnancy or while breastfeeding?

It should not be used if you have kidney problems, diabetic coma or ketoacidosis, chronic kidney disease, heart failure, trauma, dehydration, alcohol dependence, or if you are pregnant or breastfeeding. It is not recommended during pregnancy or breastfeeding.

Indications

Glipizide & Metformin is indicated as initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone and as second-line therapy when diet, exercise, and initial treatment ... Read moreGlipizide & Metformin is indicated as initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone and as second-line therapy when diet, exercise, and initial treatment with a Sulfonylurea or Metformin do not result in adequate glycemic control in patients with type 2 diabetes

Pharmacology

Metformin is a biguanide antihyperglycemic agent, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its pharmacological mechanisms of action are different from other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike sulfonylurea, metformin does not produce hypoglycemia in either patient with type 2 diabetes or normal subjects and does not cause hyperinsulinemia.

Glipizide is a sulfonylurea which appears to lower blood glucose by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Extrapancreatic effects may play a part in the mechanism of action of oral sulfonylurea hypoglycemic drugs.

Dosage & Administration

Glipizide & Metformin should be given once or twice daily with meals and should be initiated at a low dose, with gradual dose escalation.

Glipizide & Metformin as Initial Therapy: The recommended starting dose is 250 mg/2.5 mg once a day with meal.

Glipizide & Metformin as Second-Line Therapy: The recommended starting dose is 500 mg/2.5 mg or 500 mg/5 mg twice daily with the morning and evening meals. The maximum recommended daily dose is 2000 mg Metformin/20 mg Glipizide.

Interaction

Cimetidine reduces the renal clearance of Metformin. Alcohol potentiates the antihyperglycemic & hyperlactataemic effect of Metformin. It may enhance the effects of anti-coagulants. Such patients receiving the two drugs may need adjustment of the anti-coagulant dosage. Nifedipine appears to enhance the absorption of Metformin but Metformin has minimal effects on Nifedipine. The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.

Contraindications

Hypersensitivity to the drug, renal impairment, diabetic coma and ketoacidosis, chronic renal diseases, congestive heart failure, trauma, dehydration, alcohol dependence, pregnancy, breast-feeding etc.

Side Effects

The most common side effects of Glipizide & Metformin are hypoglycemia,
diarrhea, nausea/vomiting, abdominal pain, headache, musculoskeletal pain etc.

Pregnancy & Lactation

Contraindicated during Pregnancy & Lactation

Precautions & Warnings

Metformin is known to be substantially excreted by the kidney, and the risk of Metformin accumulation and lactic acidosis is increased with the degree of impairment of renal function. Thus, patients with serum creatinine levels above the upper limit of normal should not receive Metformin. In patients with advanced age, Metformin should be carefully titrated to establish minimum dose for adequate glycemic control, because aging is associated with reduced renal function. Metformin therapy should be temporarily suspended for any surgical procedure and should not be restarted until the patient’s oral intake has resumed and renal function has been evaluated as normal. During concomitant therapy with sulfonylurea, blood glucose should be monitored. Metformin & insulin therapy should be carried out in hospital until the correct ratio of the two drugs has been established. The metabolism and excretion of Glipizide may be slowed in patients with impaired renal and/or hepatic function. If hypoglycemia should occur in such patients, it may be prolonged and appropriate management should be instituted.

Storage Conditions

Store below 25ºC in a cool and dry place.

Alternative brands of Glipizide + Metformin Hydrochloride

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.